Heidelberg Pharma AG Logo

Heidelberg Pharma AG

ISIN: DE000A11QVV0 | Ticker: HPHA | LEI: 391200E09XYBYITR1W32
Sector: Health Care – Sub-Industry: Pharmaceuticals
Country: Germany
Website Investor Relations

About Heidelberg Pharma AG

Company Description

Heidelberg Pharma AG based in Ladenburg, Germany, is a biopharmaceutical company listed on the Frankfurt Stock Exchange in the Regulated Market / Prime Standard. The Company was founded in September 1997 by a team of physicians and oncologists from the Technical University of Munich. In 2000, the Company changed to an AG from a GmbH legal structure. In 2011, the subsidiary Heidelberg Pharma Research GmbH was acquired.
Heidelberg Pharma was restructured in 2014, which led to the discontinuation of all research and development activities in Munich. The shareholder’s meeting in July 2017 decided to move the registered office of WILEX AG from Munich to Ladenburg and to change the name of the Company to Heidelberg Pharma AG. The subsidiary Heidelberg Pharma GmbH is now named Heidelberg Pharma Research GmbH.

Year founded

1997

Served area

Worldwide

Headcount

96

Headquarters

Gregor-Mendel-Straße 22, 68526 Ladenburg – Germany

Filings & Publications

2022
2021
2020
2019
2018
2017

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
ENG
ENG
GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
GER / ENG
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2019

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
ENG / GER
GER / ENG
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2018

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
ENG / GER
ENG / GER
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2017

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
ENG / GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
13.10.22 4H invest GmbH Close relation Other EUR 993,666.24
13.10.22 Bohlini invest GmbH Close relation Other EUR 964,061.56
13.10.22 MH-LT-Investments GmbH Close relation Other EUR 506,241.96
13.10.22 Schneiders, Michael Board Buy EUR 13,088.40
13.10.22 Schneiders, Michael Board Buy EUR 4,895.60
07.09.22 Plate, Achim Board Buy EUR 30,869.92
06.09.22 Kudlek, Dr. Birgit Supervisory board Other EUR 7,496.16
22.03.22 4H invest GmbH Close relation Other EUR 0.00
16.03.22 WAOW entrepreneurship GmbH Close relation Buy EUR 494,208.00
16.03.22 Beretti, Giulio Other Buy EUR 4,025.00

Capital markets information

ISIN

DE000A11QVV0

LEI

391200E09XYBYITR1W32

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Designated Sponsor

Pareto Securities

Stifel Europe Bank AG

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.